David Collard

Title: David Collard - Innovator in Heterocyclic Compounds

Introduction

David Collard is a notable inventor based in Beckenham, Kent, GB. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on heterocyclic compounds.

Latest Patents

David Collard holds a patent for a compound titled "3-Amino-1-phenyl-2-pyrazolines." This invention involves heterocyclic compounds of formula (I) and their acid addition salts, which inhibit arachidonic acid oxygenation. These compounds are particularly useful in medicine, serving as anti-inflammatory agents. The compounds can be prepared using methods analogous to those known in the art, such as the method described by G. F. Duffin and J. D. Kendall in the Journal of Chemical Society in 1954. When utilized in medical applications, these compounds may be administered alone or as part of a pharmaceutical formulation combined with a pharmaceutically acceptable carrier. David Collard has 1 patent to his name.

Career Highlights

Throughout his career, David has focused on the development of compounds that have the potential to improve health outcomes. His work has been instrumental in advancing the understanding of anti-inflammatory agents and their applications in medicine.

Collaborations

David has collaborated with notable individuals in his field, including Frederick C. Copp and Albert G. Caldwell. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

David Collard is a distinguished inventor whose work in heterocyclic compounds has significant implications for medical science. His innovative contributions continue to influence the field of medicinal chemistry.